CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-11 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,612 | $2.04 | $5K | 144,409 |
| 2018-01-11 | Ketchum Steven B Chief Scientific Officer | Sale | −2,612 | $4.40 | $11K | 141,797 |
| 2018-01-11 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −2,612 | 135,205 | ||
| 2018-01-05 | Ketchum Steven B Chief Scientific Officer | Option exercise | +64,683 | $2.04 | $132K | 206,480 |
| 2018-01-05 | Ketchum Steven B Chief Scientific Officer | Sale | −64,683 | $4.40 | $285K | 141,797 |
| 2018-01-05 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −64,683 | 137,817 | ||
| 2018-01-02 | Ketchum Steven B Chief Scientific Officer | Option exercise | +68,361 | $1.02 | $70K | 210,158 |
| 2018-01-02 | Ketchum Steven B Chief Scientific Officer | Option exercise | +59,896 | $1.40 | $84K | 270,054 |
| 2018-01-02 | Ketchum Steven B Chief Scientific Officer | Sale | −128,257 | $4.25 | $545K | 141,797 |
| 2018-01-02 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −68,361 | 25,389 | ||
| 2018-01-02 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −59,896 | 65,104 | ||
| 2017-12-31 | THERO JOHN F President and CEO | Option exercise | +37,500 | 1,172,503 | ||
| 2017-12-31 | THERO JOHN F President and CEO | Shares withheld for taxes | −15,732 | $4.01 | $63K | 1,156,771 |
| 2017-12-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −37,500 | 225,000 | ||
| 2017-12-31 | Kennedy Joseph T General Counsel | Option exercise | +47,188 | 72,741 | ||
| 2017-12-31 | Kennedy Joseph T General Counsel | Option exercise | +6,250 | 78,991 | ||
| 2017-12-31 | Kennedy Joseph T General Counsel | Shares withheld for taxes | −27,885 | $4.01 | $112K | 51,106 |
| 2017-12-31 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −47,188 | 283,124 | ||
| 2017-12-31 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −6,250 | 37,500 | ||
| 2017-11-30 | THERO JOHN F President and CEO | Purchase | +10,000 | $3.24 | $32K | 1,135,003 |
Page 88 of 95 · 1,885 trades